Drug Therapy

Co-catalytic metallopeptidases as pharmaceutical targets

Catalysis / Amyotrophic Lateral Sclerosis / Catalytic Mechanism / Tissue repair / Glutamate / Humans / Animals / Enzyme / Active site / Protease Inhibitors / Protein Degradation / Drug Therapy / Amino Acid Profile / Carboxypeptidases / Reaction Mechanism / Bacterial Infection / Cell Cycle Control / Biochemistry and cell biology / Humans / Animals / Enzyme / Active site / Protease Inhibitors / Protein Degradation / Drug Therapy / Amino Acid Profile / Carboxypeptidases / Reaction Mechanism / Bacterial Infection / Cell Cycle Control / Biochemistry and cell biology

T Helper 1–Inducing Adjuvant Protects against Experimental Paracoccidioidomycosis

Immune response / Stem Cells / Biological Sciences / Lipids / Mice / Animals / Fungal Infection / Lung / Drug Therapy / Side Effect / Enzyme Linked Immunosorbent Assay / Paracoccidioides / Control Group / Animals / Fungal Infection / Lung / Drug Therapy / Side Effect / Enzyme Linked Immunosorbent Assay / Paracoccidioides / Control Group

Questões críticas para o tratamento farmacológico da depressão pós-parto

Child Development / Postpartum Depression / Randomised Controlled Trial / Clinical Sciences / Breast feeding / Drug Therapy / Selective serotonin reuptake inhibitor / Drug Therapy / Selective serotonin reuptake inhibitor

Política de nuevos medicamentos: calidad y seguridad

Health Policy / Safety / Clinical Sciences / Drug Therapy / Atencion Primaria De La Salud

SuperNatural: a searchable database of available natural compounds

Biological Sciences / Environmental Sciences / Nucleic Acids / Computer User Interface Design / Drug Therapy / Internet / Pharmaceutical preparations / Internet / Pharmaceutical preparations

Imatinib is active in glioblastoma multiforme expressing platelet-derived growth factor receptor Imatinibe é ativo no glioblastoma multiforme com expressão do receptor do fator de crescimento derivado de plaquetas

Astrocyte / Adverse Event / Glioblastoma Multiforme / Drug Therapy / Brain Neoplasm / Therapeutic Use / Phase II Trial / Therapeutic Use / Phase II Trial

Imatinibe é ativo no glioblastoma multiforme com expressão do receptor do fator de crescimento derivado de plaquetas Imatinib is active in glioblastoma multiforme expressing platelet-derived growth factor receptor

Astrocyte / Adverse Event / Glioblastoma Multiforme / Drug Therapy / Brain Neoplasm / Therapeutic Use / Phase II Trial / Therapeutic Use / Phase II Trial

Questões críticas para o tratamento farmacológico da depressão pós-parto

Child Development / Postpartum Depression / Randomised Controlled Trial / Clinical Sciences / Breast feeding / Drug Therapy / Selective serotonin reuptake inhibitor / Drug Therapy / Selective serotonin reuptake inhibitor

Review of nasopharyngeal carcinoma

Magnetic Resonance Imaging / Radiotherapy / Humans / Ear Nose and Throat / Incidence / Clinical Sciences / Carcinoma / Drug Therapy / X ray Computed Tomography / Clinical Sciences / Carcinoma / Drug Therapy / X ray Computed Tomography

Soroprevalência da infecção pelo vírus da imunodeficiência humana em pacientes com tuberculose, em Londrina, Paraná

Tuberculosis / Hiv Infection / Human immunodeficiency virus / Drug Therapy / Disease Progression / Therapeutic Use / Ministry of Health / Chest X-ray / Therapeutic Use / Ministry of Health / Chest X-ray

Mediastinite aguda: análise retrospectiva de 21 casos

Staphylococcus aureus / Staphylococcus epidermidis / Perforation / Drug Therapy / Pleural Effusion / Retrospective Study / Therapeutic Use / Mortality rate / Retrospective Study / Therapeutic Use / Mortality rate

Tratamento cirúrgico da epilepsia do lobo temporal: análise de 43 casos consecutivos

Cognitive Science / Brain Tumor / Temporal Lobe / Temporal Lobe Epilepsy / Clinical Sciences / Drug Therapy / Postoperative Complication / Arq / Epilepsy Surgery / Mesial Temporal Sclerosis / Surgical Treatment / Drug Therapy / Postoperative Complication / Arq / Epilepsy Surgery / Mesial Temporal Sclerosis / Surgical Treatment
Copyright © 2017 DADOSPDF Inc.